More bad news for psychedelic drug company: FDA expands probe after rejection
trippy journey up– Hallucinogen business Lykos currently slashed personnel and upgraded management. Beth Mole – Aug 26, 2024 9:58 pm UTC Expand / President of Multidisciplinary Association for Psychedelic Studies…
Read More »